{"id":"NCT01190176","sponsor":"GlaxoSmithKline","briefTitle":"Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects","officialTitle":"Gynaecological Follow-up of a Subset of HPV-015 Study Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09-12","primaryCompletion":"2017-09-20","completion":"2017-09-20","firstPosted":"2010-08-27","resultsPosted":"2018-10-17","lastUpdate":"2019-10-30"},"enrollment":34,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Papillomavirus"],"interventions":[{"type":"PROCEDURE","name":"Gynaecological follow-up","otherNames":[]},{"type":"BIOLOGICAL","name":"Cervarix","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo control","otherNames":[]}],"arms":[{"label":"HPV-062 study subjects Group","type":"EXPERIMENTAL"}],"summary":"This study is intended to provide up to a maximum of four years of annual oncogenic human papillomavirus (HPV) DNA testing and cervical cytology examination for NCT00294047 study subjects who displayed normal cervical cytology but tested positive for oncogenic HPV infection at their concluding NCT00294047 study visit.\n\nWomen who were pregnant at their concluding NCT00294047 study visit may also be included in this study, as no cervical sample could be collected at that visit.\n\nThe objectives and outcome measures of the primary phase (NCT00294047) are presented in a separate protocol posting.","primaryOutcome":{"measure":"Number of Subjects Reporting Positive Oncogenic HPV DNA Results by Hybrid Capture II Test (HCII) at Month 12","timeFrame":"At Month 12 [12 months post concluding HPV-015 visit (Visit 9, Visit 11 or last HPV-015 study visit)]","effectByArm":[{"arm":"HPV-062 Study Subjects Group","deltaMin":2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"28 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":20,"countries":["United States","Canada","Netherlands","Portugal","Russia","Singapore","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":32},"commonTop":[]}}